T6	Treatment 0 30	High-dose cytosine arabinoside
T9	Treat-Disorder 57 82	refractory acute leukemia
T8	Subject 43 82	patients with refractory acute leukemia
T10	Speculation_cue 31 34	may
T11	Dosage 0 9	High-dose
T12	Drug 10 30	cytosine arabinoside
T7	Potential_therapeutic_event 35 42	benefit
E1	Potential_therapeutic_event:T7 
